Common TitleC-ISLE
Official Title Elbasvir/grazoprevir and sofosbuvir for hepatitis C virus genotype 3 infection with compensated cirrhosis: A randomized trial.
Phase Phase II
ClinicalTrials.gov NCT02601573
Treatments
Elbasvir-Grazoprevir

Elbasvir-Grazoprevir
Tradename:ZepatierOther Names:EBR-GZRClass:FDA-ApprovedFunding
IndustryMerck Sharp & Dohme Corp.